Online inquiry

IVTScrip™ mRNA-Human ARHGAP26, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26791MR)

This product GTTS-WK26791MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGAP26 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001135608.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23092
UniProt ID Q9UNA1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP26, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26791MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK17963MR IVTScrip™ mRNA-Human ANXA5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANXA5
GTTS-WK12773MR IVTScrip™ mRNA-Human ACTR3B, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ACTR3B
GTTS-WK17028MR IVTScrip™ mRNA-Human ANKRD46, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD46
GTTS-WK15262MR IVTScrip™ mRNA-Human ANXA4, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANXA4
GTTS-WK14968MR IVTScrip™ mRNA-Human AOAH, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AOAH
GTTS-WK14836MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA alpha-Sarcoglycan
GTTS-WK26896MR IVTScrip™ mRNA-Human ASB15, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASB15
GTTS-WK28344MR IVTScrip™ mRNA-Human ARL5A, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARL5A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW